People with type 1 diabetes – a lifelong condition — who used a bionic pancreas instead of manually monitoring glucose using fingerstick tests and delivering insulin using a pump were more likely to have blood glucose levels consistently within the normal range, with fewer dangerous lows or highs. The full report of the findings, funded by the National Institutes of Health, was published June 15th 2014 in the New England Journal of Medicine.